3. CONSTIPATION
Constipation is one of the most common gastrointestinal
disorders encountered in clinical practice.
Up to one-fifth of the general population suffers from chronic
constipation during their lifetime.
Am J Gastroenterology 2012;107:18-25.
It is estimated that 130 million Indians suffer from constipation
Special report from World Gastroenterology Organization
4. CHRONIC CONSTIPATION
Hard feces that are difficult to expel.
Colon absorbed too much water from
the food while passing through it.
Food moves slow through the
digestive tract, consequently the
feces become dry and hard.
7. SYMPTOMS
Symptoms include:
Stomach ache
Stomach cramps
Feeling bloated and nauseous
Losing appetite
Difficulty and straining
Passing less stools than usual
8. DIAGNOSIS
The doctor may suggest the following tests to rule out other health
conditions:
Blood tests
Sigmoidoscopy
Colonoscopy
Balloon expulsion test
Anorectal manometry
9. TREATMENT
Stimulants: These make the muscles in
the intestines contract rhythmically.
Lubricants: These help the stool move
down the colon more easily.
Stool softeners: These moisten the
stool.
Fiber supplements: Called as bulk
laxatives.
10. TREATMENT
Osmotics: These facilitate the movement
of fluids through the colon.
Saline laxatives: These draw water into
the colon.
Chloride channel activators: These
require a prescription and include
lubiprostone.
5-HT-4 agonists: Increase secretion of
fluid in intestines and speed up the rate at
which food passes through the colon.
12. RISKS ASSOCIATED WITH LAXATIVE THERAPY
Cramping, bloating, and nausea in
some people.
Dependent on laxatives and may mask
important constipation symptoms.
Laxatives interfere with absorption of
other medications, avoid taking laxative
two hours of taking other medications.
Laxative abuse result in dangerous
dehydration, weakness, fainting, and
kidney damage.
13. LAXATIVE ABUSE
Electrolyte and mineral imbalances
Severe dehydration
Laxative dependence
Chronic constipation
Internal organ damage
Increased colon cancer risk
14. PRUCALOPRIDE
Agonist of 5HT4 receptors found in the
gut.
Chronic constipation and slow transit,
develop tolerance, are also eligible for
Prucalopride treatment.
Most of the dose is excreted unchanged
in the urine.
Cisapride and Tegaserod removed
because of serious cardiovascular
adverse effects.
18. MARKET & COMPETITORS
Total No. of Brands = 7
Total Market 17.98 Crs
BRAND LAUNCH DATE COMPANY MAT VAL FEB 18
Grand Total 17.98
PRUVICT Apr-17 TORRENT 12.28
PRESMOVAC Jun-17 TORRENT 2.22
CONSTICALO Jun-17 TORRENT 1.90
PRUEASE Dec-17 SUN 0.77
PRUWEL Dec-17 INTAS 0.63
PRUDAC Jan-18 ZYDUS CADILA 0.16
MUVPRU Jan-18 EMCURE 0.02
As per Awacs AIOCD Feb’18
21. DOSAGE
Recommended adult dose for Prulitop 2 mg once daily with or without
food, at any time of the day.
Older people (>65 years): Start with 1 mg once daily, if needed the
dose can be increased to 2 mg once daily.
Patients with renal impairment: The dose for patients with severe
renal impairment (GFR < 30 ml/min) is 1 mg once daily.